Your browser doesn't support javascript.
loading
Research progress on the interaction between long non­coding RNAs and RNA­binding proteins to influence the reprogramming of tumor glucose metabolism (Review).
Wu, Weizheng; Wen, Kunming.
Afiliação
  • Wu W; Department of General Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
  • Wen K; Department of General Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Oncol Rep ; 48(3)2022 Sep.
Article em En | MEDLINE | ID: mdl-35856447
ABSTRACT
As epigenetic regulators, long non­coding RNAs (lncRNAs) are involved in various important regulatory processes and typically interact with RNA­binding proteins (RBPs) to exert their core functional effects. An increasing number of studies have demonstrated that lncRNAs can regulate the occurrence and development of cancer through a variety of complex mechanisms and can also participate in tumor glucose metabolism by directly or indirectly regulating the Warburg effect. As one of the metabolic characteristics of tumor cells, the Warburg effect provides a large amount of energy and numerous intermediate products to meet the consumption demands of tumor metabolism, providing advantages for the occurrence and development of tumors. The present review article summarizes the regulatory effects of lncRNAs on the reprogramming of glucose metabolism after interacting with RBPs in tumors. The findings discussed herein may aid in the better understanding of the pathogenesis of malignancies, and may provide novel therapeutic targets, as well as new diagnostic and prognostic markers for human cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncol Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncol Rep Ano de publicação: 2022 Tipo de documento: Article